drugset / Trial / NCT06432647
A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105
RandomizedSequentialQuadruple-blindOther
Summary
The goal of this Phase 1 interventional study is to assess the safety, tolerability and pharmacokinetics of ATH-1105 in healthy male and female participants.
Timeline
- Start
- 2024-04-24
- Primary completion
- 2024-11-25
- Completion
- 2024-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATH-1105 | Unknown | — | Oral |
Indications
No indication recorded.